Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Urinary bladder tumours. The new 2004 WHO classification].

M Seitz1, D Zaak, R Knüchel-Clarke

  • 1Urologische Klinik und Poliklinik, Klinikum der Universität - Grosshadern, Ludwig-Maximilians-Universität, München. Michael.Seitz@med.uni-muenchen.de

Der Urologe. Ausg. A
|September 1, 2005
PubMed
Summary

The 2004 World Health Organization classification enhances urinary bladder tumor diagnosis by standardizing urothelial tumor subgroups. This aids in correlating molecular genetics with clinical outcomes and histopathology for improved risk stratification.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urinary diversion and quality of life: A six-year follow-up study of bladder cancer surgery.

Actas urologicas espanolas·2025
Same author

[Establishment of a German ICCR dataset : Translation and integration of SNOMED CT using the example of TUR-B].

Pathologie (Heidelberg, Germany)·2024
Same author

Single-fraction image-guided robotic radiosurgery efficiently controls local prostate cancer recurrence after radical prostatectomy.

BJUI compass·2022
Same author

Polyethylene glycol-coated collagen patch (hemopatch<sup>®</sup>) in open partial nephrectomy.

World journal of urology·2021
Same author

The HELENA study: Hexvix<sup>®</sup>-TURB vs. white-light TURB followed by intravesical adjuvant chemotherapy-a prospective randomized controlled open-label multicenter non-inferiority study.

World journal of urology·2021
Same author

Postoperative change in Gleason score of prostate cancer in fusion targeted biopsy: a matched pair analysis.

Scandinavian journal of urology·2020

Area of Science:

  • Urothelial carcinoma research
  • Molecular genetics of bladder cancer
  • Tumor classification and pathology

Context:

  • Advances in molecular genetics have improved understanding of urinary bladder carcinoma.
  • Correlation of morphological classification with clinical outcomes and histopathology is crucial.
  • Previous classifications lacked standardized subgroup definitions for urothelial tumors.

Purpose:

  • To present the new 2004 World Health Organization (WHO) classification for urinary bladder tumors.
  • To highlight changes from previous classifications, focusing on histological typing, grading, and molecular characterization.
  • To emphasize the importance of standardized diagnosis for comparing global trials and stratifying risk profiles.

Summary:

  • The 2004 WHO classification provides standardized diagnostic criteria for urothelial tumors, defining subgroups more precisely.

Related Experiment Videos

  • This classification facilitates correlation between molecular genetic findings, histopathology, and clinical outcomes.
  • Future research may refine this scheme using molecular techniques and immunohistochemistry for identifying genetically unstable tumors.

    • Impact:

    • Enables standardized diagnosis and comparison of clinical trials worldwide.
    • Facilitates accurate risk stratification for patients with urinary bladder tumors.
    • Lays the groundwork for future refinements in bladder cancer classification and targeted therapies.